期刊文献+

矽肺病患者痰液的诱导方法 被引量:1

Study on Optimizing the Sputum Induction Processes in Patient with Silicosis
原文传递
导出
摘要 [目的]通过优化痰液诱导和处理条件,探讨适宜的痰液诱导和处理方法。[方法]以不同浓度的高渗盐溶液、不同诱导时间对40例Ⅰ期矽肺患者进行雾化痰液诱导;用不同稀释倍数的0.1%二硫苏糖醇(DTT)及不同的水浴时间对痰液进行处理。[结果]3%、4%、5%浓度高渗盐水诱导成功率分别为80.00%、82.50%、60.00%;而6%浓度仅为22.50%,明显低于3%、4%、5%溶液(P〈0.01);4%、5%之间的差异有统计学意义(P〈0.05);3%、4%之间的差异无统计学意义(P〉0.05)。3%浓度高渗盐水诱导时间25、30 min的成功率分别为77.50%、92.50%。痰液37℃水浴30、40、50 min溶解状况明显优于20 min,差异有统计学意义(P〈0.05);而30 min、40 min、50 min水浴差异无统计学意义(P〉0.05)。4倍DTT与2倍体积DTT稀化对痰液溶解状况及痰液中IL-6和TNF-α水平均无明显影响(P〉0.05)。[结论]以3%、4%的高渗盐水雾化吸入20、30 min痰液诱导满意率较高且得到的痰液质量较佳,经过水浴30-40 min,加入2倍或4倍0.1%DTT处理的稀化程度较好。 [Objective] To optimizing the solution concentration and procedures of pre-treatment in sputum analyses among patient with respiratory disease.[Methods] Results of sputum induction with various solution and treatment in 40 patients with silicosis were compared.[Results] Success result of sputum induction was obtained in rates of 80.00%,82.50%,60.00%,and 22.50% from inhalation of mist of 3%,4%,5%,and 6% hypertonic saline solution respectively.The differences between 4% and 5% to all others were statistically significant(P〈0.05).Rate of successful result for 25 to 30 min.induction were 77.50% and 92.50%,respectively.Better result in dissolution and no influence level in detecting IL-6 and TNF-α were obtained from 30-50 min 37 ℃ water bath than less than 20 min.in 2-4 fold dilution of 0.1% DTT(P〉0.05).[Conclusion] The optimized condition for sputum induction was find of spraying mist of 3%-4% hypertonic saline for 20-30 min.Better consequent pre-treatment was 37℃ water bath incubation in 2-4 folds dilution with 0.1% DTT solution for 30-40 min.
出处 《环境与职业医学》 CAS 北大核心 2010年第7期449-452,共4页 Journal of Environmental and Occupational Medicine
基金 国家自然科学基金资助项目(编号:30872094) 山东省科技攻关项目(编号:2008GG30002036)
关键词 痰液诱导 痰液处理 矽肺 二硫苏糖醇 sputum induction pretreatment for the induced sputum silicosis dithiotheoritol(DTT)
  • 相关文献

参考文献11

  • 1BICKERMAN H A, SPROUL E E, BARACH A L. An aerosol method of producing bronchial secretions in human subjects: a clinical technic for the detection of lung cancer[ J ]. Dis Chest, 1958, 33( 4 ): 347-362.
  • 2PIN I, GIBSON PG, KOLENDOWICZ R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma [ J ]. Thorax, 1992, 47( 1 ): 25-29.
  • 3AITKEN ML, GREENE KE, TONELLI MR, et al. Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis [ J ]. Chest, 2003, 123 (3): 792-799.
  • 4RODWELL LT, ANDERSON S D. Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis : a pilot study [ J ]. Pediatr Pulmonol, 1996, 21 ( 5 ): 282-289.
  • 5FAHY J V, WONG H, LIU J, et al. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects[ J ]. Am J Respir Crit Care Med, 1995, 152( 1 ): 53-58.
  • 6KELLY M G, BROWN V, MARTIN SL, et al. Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD [ J ]. Chest, 2002, 122( 3 ): 955-959.
  • 7CHELAND W W. Dithiotheritol, a new protective reagent for SH groups[ J ]. Biochemistry, 1964, 3: 480-482.
  • 8EFTHIMIADIS A, PIZZICHINI M M, PIZZICHINI E, et al. Induced sputum cell and fluid-phase indices of inflammatory : comparison of treatment with dithiothreitol vs phosphate-buffered saline [ J ]. Eur RespirJ, 1997, 10(6): 1336-1340.
  • 9LOUIS R, SHUTE J, GOLDRING K, et al. The effect of processing on inflammatory markers in induced sputum[ J]. Eur Respir J, 1999, 13 ( 3 ) 660-667.
  • 10GREBSKI E, PETERSON C, MEDICI T C. Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients[ J ]. Chest, 2001, 119( 5 ): 1521-1525.

同被引文献12

  • 1孙自勤,王要军,权启镇,齐凤,张志坚,韩刚毅,靳晓红,阎祥华.血清PⅢP、PCⅢ、HA、LN和PE测定在实验性肝纤维化诊断与疗效考核中的意义[J].实用肝脏病杂志,1996,1(2):74-76. 被引量:6
  • 2姜晓红,李超乾.诱导痰的研究进展[J].国外医学(呼吸系统分册),2005,25(6):443-445. 被引量:27
  • 3Bickerman HA, Sproul EE, Barach AL. An aerosol method of producing bronchial secretions in human subjects: a clinical technic for the detection of lung cancer [J]. CHEST Journal, 1958, 33 (4): 347-362.
  • 4Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. [J]. Thorax, 1992, 47( 1 ):25-29.
  • 5Sullivan DE,Fen'is M,Pociask D,et al.Tumor necrosis factor-or induces transforming growth factor? 1 expression in lung fibroblasts through the cxtracellular signal regulated kinase pathway[J]. Am J Respir Cell Mol Biol,2005,32 (4) : 342-349.
  • 6Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1- mediated apoptosis is essential for transforming growth factor betal- induced pulmonary fibrosis.[J]. J Exp Med,2004, 200(3 ):377-389.
  • 7Lasky JA, Brody AR. Interstitial Fibrosis and Growth Factors [J]. Environ Health Perspect, 2000, 108 ( 8 ):751-762.
  • 8Finlay GA, O' Driscoll LR, Russell KJ, et al. Matrix metallopro- teinases expression and production by alveolar macrophages in em- physema[J].Am J Respir Crit Care Med,1997;156:240-247.
  • 9Boitelle A, Gosset P, Copin M C, et al. MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis[J]. Eur Respir J, 1997, 10(3): 557-562.
  • 10Chung A S, Kao W J. Fibroblasts regulate monocyte response to ECM-derived matrix: The effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins[J]. J Biomed Mater Res A, 2009, 89(4): 841-853.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部